HIV infections Trials in Omaha, United States
Conditions / HIV infections / Omaha, United States
HIV infections has been the subject of sustained clinical investigation across multiple research sites.
79 total trials for this combination
Showing top 10 of 79 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00002123 | A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3 | COMPLETED | PHASE3 |
| NCT00000638 | Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection | COMPLETED | NA |
| NCT01231516 | A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults | COMPLETED | PHASE3 |
| NCT02951052 | Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00013897 | A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine | COMPLETED | PHASE3 |
| NCT05911360 | A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00000841 | A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months | COMPLETED | PHASE3 |
| NCT03299049 | Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00002124 | A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3 | COMPLETED | PHASE3 |
| NCT00001137 | Long-Term Data Collection From Participants in Adult AIDS Clinical Trials | COMPLETED | — |